Readmission After Adrenalectomy
Early Readmission After Adrenalectomy for PHEO.
1 other identifier
observational
346
0 countries
N/A
Brief Summary
to evaluate early hospital enterance after pheo surg.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 18, 2024
CompletedFirst Posted
Study publicly available on registry
November 20, 2024
CompletedNovember 20, 2024
November 1, 2024
8 years
November 18, 2024
November 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
readmission rate
number of hospital readmission
30 days
Study Arms (1)
hospital readmission
hospital readmission for complications
Interventions
Eligibility Criteria
patients with pheo
You may qualify if:
- patients with pheo
You may not qualify if:
- non reactive
- missed data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- prof
Study Record Dates
First Submitted
November 18, 2024
First Posted
November 20, 2024
Study Start
September 1, 2016
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
November 20, 2024
Record last verified: 2024-11